Home
Live Updates
DFF332 Elicits Efficacy and Is Safe in Advanced Clear Cell RCC : comparemela.com
DFF332 Elicits Efficacy and Is Safe in Advanced Clear Cell RCC
The small molecule inhibitor DFF332 elicited clinical activity and had a tolerable safety profile in patients with advanced clear cell renal cell carcinoma.
Related Keywords
California ,
United States ,
Sumanta Kumar Pal ,
Bladder Cancer Disease Team ,
Kidney Cancer Program ,
Database Consortium ,
International Metastatic ,
Medical Oncology ,
Therapeutics Research ,
Hope Comprehensive Cancer Center ,
comparemela.com © 2020. All Rights Reserved.